세계의 콜레스테롤 검사 시장 보고서(2025년)
Cholesterol Test Global Market Report 2025
상품코드 : 1824354
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,546,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,462,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,378,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

콜레스테롤 검사 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2029년에는 CAGR 8.9%를 나타내 139억 5,000만 달러로 성장할 것으로 예상됩니다. 예측 기간의 성장은 기업의 웰빙에서의 통합, 정밀영양의 영향, 건강지향의 소비자주의, 유전자검사의 통합, 개별화의 의료의 이동에 기인하는 것으로 예측됩니다. 예측 기간의 주요 동향으로는 콜레스테롤을 표적으로 한 치료, 건강 앱과의 통합, 콜레스테롤 교육 플랫폼, 종합적 지질 패널, POC(Point-of-Care) 검사 확대 등이 있습니다.

향후 5년간의 성장률 8.9%라고 하는 예측은 전회 예측으로부터 0.2%의 소폭의 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 관세의 부과는 네덜란드와 스웨덴에서 직접 수입되는 저비중 지단백 콜레스테롤(LDL-C) 분석기와 지질 패널 시약에 대한 접근을 제한하고 심혈관 위험 평가를 늦추거나 검사 비용을 증가시킬 수 있기 때문에 미국의 예방 심장학에 과제를 초래할 수 있습니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계경제와 무역에 대한 악영향으로 인해 그 영향이 더욱 광범위하게 됩니다.

심혈관 질환의 유병률 증가는 콜레스테롤 검사 시장 성장을 가속할 것으로 예측됩니다. 심혈관 질환(CVD)은 관상동맥성 심장 질환, 뇌졸중, 말초 동맥 질환, 대동맥 질환 및 기타 관련 질환을 포함한 다양한 심장 및 혈관 장애를 포함합니다. 콜레스테롤 검사는 심장 질환의 발병 위험과 관련하여 개인 및 건강 관리 제공업체에게 필수적인 정보를 제공합니다. 예를 들어, 2024년 6월 호주 정부 기관인 호주 보건복지연구소는 2021년 관상동맥성 심장병(CHD)으로 인한 의사가 인정한 사망자 수는 1만 4,100명으로 2022년에는 1만 4,900명으로 증가했다고 보고했습니다. 그 결과, 사망률의 상승과 심혈관 질환의 만연이 콜레스테롤 검사 시장에 박차를 가하게 됩니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

KTH
영문 목차

영문목차

A cholesterol test involves analyzing blood to measure the levels of cholesterol and other lipids present. Cholesterol, a waxy, fat-such as substance, is essential in small amounts for maintaining overall health.

The primary cholesterol test products include test kits, test strips, and other related items. Test kits are devices designed to monitor or detect specific chemical residues or attributes in an individual's blood. Cholesterol test kits are particularly convenient for home use, enabling individuals to monitor their cholesterol levels without the need for a visit to a healthcare facility. The various types of cholesterol tests include total cholesterol, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, and triglycerides or very low-density lipoprotein (VLDL) cholesterol tests. These cholesterol test products are distributed through over-the-counter and prescription-based channels, reaching various end-users such as hospitals, diagnostic centers, and other healthcare facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The cholesterol test market research report is one of a series of new reports from The Business Research Company that provides cholesterol test market statistics, including cholesterol test industry global market size, regional shares, competitors with a cholesterol test market share, detailed cholesterol test market segments, market trends and opportunities, and any further data you may need to thrive in the cholesterol test industry. This cholesterol test market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cholesterol test market size has grown strongly in recent years. It will grow from $9.16 billion in 2024 to $9.94 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to cardiovascular disease awareness, research on heart health, public health campaigns, physician recommendations, patient education.

The cholesterol test market size is expected to see strong growth in the next few years. It will grow to $13.95 billion in 2029 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to integration in corporate wellness, precision nutrition influence, health-conscious consumerism, genetic testing integration, personalized medicine shift. Major trends in the forecast period include cholesterol-targeted therapies, integration with health apps, cholesterol education platforms, comprehensive lipid panels, point-of-care testing expansion.

The forecast of 8.9% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may pose challenges for U.S. preventive cardiology by restricting access to direct Low-Density Lipoprotein Cholesterol(LDL-C) analyzers and lipid panel reagents imported from the Netherlands and Sweden, potentially delaying cardiovascular risk assessment and increasing lab costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of cardiovascular diseases is anticipated to drive the growth of the cholesterol test market. Cardiovascular diseases (CVDs) encompass a range of heart and blood vessel disorders, including coronary heart disease, stroke, peripheral arterial disease, aortic disease, and other related conditions. Cholesterol tests provide essential information to individuals and healthcare providers regarding the risk of developing heart disease. For example, in June 2024, the Australian Institute of Health and Welfare, an Australian government agency, reported that in 2021, there were 14,100 doctor-certified deaths attributed to coronary heart disease (CHD), rising to 14,900 in 2022. Consequently, the increasing rates of mortality and the prevalence of cardiovascular diseases will fuel the cholesterol test market.

The burgeoning aging population is poised to be a significant catalyst for the growth of the cholesterol test market in the foreseeable future. An aging population denotes a demographic shift characterized by a rising proportion of elderly individuals within a society. As part of proactive healthcare strategies, the aging population extensively utilizes cholesterol tests to effectively manage cardiovascular health and mitigate the risks associated with age-related ailments. This trend aligns with a preventative healthcare approach aimed at promoting overall well-being. As highlighted by the World Health Organization (WHO) in October 2022, the global population aged 60 years and older is experiencing rapid growth, projected to double by 2050, reaching a staggering 2.1 billion individuals. Consequently, the expanding aging demographic emerges as a significant driver in fueling the growth trajectory of the cholesterol test market.

Technological advancements are significantly shaping the landscape of the cholesterol test market, with prominent companies and research institutions actively driving innovation for more cost-effective, efficient, and advanced testing solutions. For instance, in November 2022, Ural Federal University (UrFU), a Russian-based institution, unveiled a cutting-edge microfluidic chip. This sensor device, fabricated via 3D printing, integrates all system elements required for measuring blood cholesterol levels. The novel sensor technology employed in this chip remarkably reduces the necessary blood volume for cholesterol level identification. The analysis involves placing blood in an analyzing chip containing an acetonitrile-based copper chloride solution. Equipped with an electrode connected to a voltametric analyzer, this innovation utilizes magnetic nanoparticles integrated with polymers featuring molecular imprints. These imprints selectively absorb cholesterol, effectively filtering out other essential blood elements, thereby expediting analysis results.

Major entities within the cholesterol test market are actively pioneering innovative solutions, including MOT diagnostic tests, to advance cholesterol testing methodologies. For instance, Goodbody Health Ltd., a UK-based healthcare company, introduced its Health 'MOT' diagnostic test in May 2022. This comprehensive diagnostic evaluation offers an inclusive summary of an individual's health status and includes pioneering in-clinic tests for diabetes and cholesterol. Providing rapid results within minutes, these tests assess an individual's risk of developing cardiac health issues or diabetes over the subsequent decade. This innovative approach significantly enhances the efficiency and scope of cholesterol testing, contributing to more holistic health assessments.

In January 2023, South Korea-based diagnostics reagents company SD Biosensor, Inc., and Korean private equity investment firm SJL Partners successfully acquired Meridian Bioscience, Inc. for $1.53 billion. This strategic acquisition is geared towards enhancing Meridian Bioscience, Inc's ability to meet the growing demand for diagnostic testing services and to innovate new solutions. By leveraging SD Biosensor's industry experience and complementary capabilities, Meridian Bioscience, Inc aims to strengthen its position in the market. As a U.S.-based life science company, Meridian Bioscience, Inc specializes in manufacturing, marketing, and selling novel diagnostic devices, particularly in the areas of cholesterol and cardiac testing.

Major companies operating in the cholesterol test market include CVS Health Corporation, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers GmbH, Fujifilm Holdings Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, Mindray Medical International Limited, SYNLAB International GmbH, Beckman Coulter Inc., PerkinElmer Inc., Horiba Ltd., Sigma-Aldrich Corp, Randox Laboratories Ltd., Nova Biomedical Corp, Abcam plc, Sinocare Inc., ACM Global Laboratories, Clinical Reference Laboratory Inc., Sekisui Diagnostics LLC, Everlywell Inc., SpectraCell Laboratories Inc., Spectra Laboratories Inc., LetsGetChecked USA, Ulta Lab Tests LLC, Cell Biolabs Inc., BioReference Health LLC, Diazyme Laboratories Inc.

North America was the largest region in the cholesterol test market in 2024. The regions covered in the cholesterol test market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cholesterol test market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cholesterol test market includes revenues earned by entities by providing various services such as clinical laboratory testing, online lab tests, medical advice, and diagnosis. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The cholesterol test market also consists of sales of handheld point-of-care testing (POCT) devices, automated analyzers, lancets, and capillaries. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cholesterol Test Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cholesterol test market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for cholesterol test ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cholesterol test market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Cholesterol Test Market Characteristics

3. Cholesterol Test Market Trends And Strategies

4. Cholesterol Test Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Cholesterol Test Growth Analysis And Strategic Analysis Framework

6. Cholesterol Test Market Segmentation

7. Cholesterol Test Market Regional And Country Analysis

8. Asia-Pacific Cholesterol Test Market

9. China Cholesterol Test Market

10. India Cholesterol Test Market

11. Japan Cholesterol Test Market

12. Australia Cholesterol Test Market

13. Indonesia Cholesterol Test Market

14. South Korea Cholesterol Test Market

15. Western Europe Cholesterol Test Market

16. UK Cholesterol Test Market

17. Germany Cholesterol Test Market

18. France Cholesterol Test Market

19. Italy Cholesterol Test Market

20. Spain Cholesterol Test Market

21. Eastern Europe Cholesterol Test Market

22. Russia Cholesterol Test Market

23. North America Cholesterol Test Market

24. USA Cholesterol Test Market

25. Canada Cholesterol Test Market

26. South America Cholesterol Test Market

27. Brazil Cholesterol Test Market

28. Middle East Cholesterol Test Market

29. Africa Cholesterol Test Market

30. Cholesterol Test Market Competitive Landscape And Company Profiles

31. Cholesterol Test Market Other Major And Innovative Companies

32. Global Cholesterol Test Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cholesterol Test Market

34. Recent Developments In The Cholesterol Test Market

35. Cholesterol Test Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기